Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Frontiers in Neurology|June 1, 2022
Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the "Attikon" Lupus CohortDionysis Nikolopoulos, Dimitrios Kitsos, Matilda Papathanasiou, et al.
Rheumatology and Therapy|June 18, 2026
Optical Spectral Transmission Imaging in Patients with Osteoarthritis: A Comparative Study with Joint Ultrasound and Clinical MarkersKonstantinos Triantafyllias, Stefanie Liverakos, Khalid K Altamimi, et al.
RMD Open|July 3, 2026
Belimumab outperforms placebo for attainment of modified DORIS remission and LLDAS without the glucocorticoid component: a post hoc analysis of five phase III SLE trialsIoannis Parodis, Julius Lindblom, Roger A Levy, et al.
Annals of the Rheumatic Diseases|November 10, 2019
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatmentChristina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, et al.
Rheumatology (Oxford, England)|January 6, 2021
Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohortDionysis Nikolopoulos, Dimitris Kitsos, Matilda Papathanasiou, et al.
Science Advances|October 28, 2022
ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosusTheodora Manolakou, Dionysis Nikolopoulos, Dimitrios Gkikas, et al.
Annals of the Rheumatic Diseases|November 30, 2019
Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosusMaria Grigoriou, Aggelos Banos, Anastasia Filia, et al.
RMD Open|October 1, 2025
Systemic lupus erythematosus damage risk index (SLE-DRI): a simple machine learning-based tool for identifying patients at risk for early organ damagePanagiotis Garantziotis, Dionysis Nikolopoulos, Spyridon Katechis, et al.
Rheumatology (Oxford, England)|March 4, 2025
Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world settingAlvaro Gomez, Tomas Walhelm, Floris C Loeff, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Remission or low disease activity at pregnancy onset are linked to improved foetal outcomes in women with systemic lupus erythematosus: results from a prospective observational studyStyliani Ntali, Dionysis Nikolopoulos, Lamprini Pantazi, et al.
Pageof 6